Nanomedicine and versatile therapies for cancer treatment
| dc.contributor.author | Shukla, Aparna | |
| dc.contributor.author | Maiti, Pralay | |
| dc.date.accessioned | 2023-04-20T05:25:54Z | |
| dc.date.available | 2023-04-20T05:25:54Z | |
| dc.date.issued | 2022-09 | |
| dc.description | This paper is submitted by the author of IIT (BHU), Varanasi | en_US |
| dc.description.abstract | The higher prevalence of cancer is related to high rates of mortality and morbidity worldwide. By virtue of the properties of matter at the nanoscale, nanomedicine is proven to be a powerful tool to develop innovative drug carriers with greater efficacies and fewer side effects than conventional therapies. In this review, different nanocarriers for controlled drug release and their routes of administration have been discussed in detail, especially for cancer treatment. Special emphasis has been given on the design of drug delivery vehicles for sustained release and specific application methods for targeted delivery to the affected areas. Different polymeric vehicles designed for the delivery of chemotherapeutics have been discussed, including graft copolymers, liposomes, hydrogels, dendrimers, micelles, and nanoparticles. Furthermore, the effect of dimensional properties on chemotherapy is vividly described. Another integral section of the review focuses on the modes of administration of nanomedicines and emerging therapies, such as photothermal, photodynamic, immunotherapy, chemodynamic, and gas therapy, for cancer treatment. The properties, therapeutic value, advantages, and limitations of these nanomedicines are highlighted, with a focus on their increased performance versus conventional molecular anticancer therapies. | en_US |
| dc.description.sponsorship | The research support grant of Tata Innovation Fellowship (sanction no. BT/HRD/35/01/02/2020) is highly acknowledged. | en_US |
| dc.identifier.issn | 26882663 | |
| dc.identifier.uri | https://idr-sdlib.iitbhu.ac.in/handle/123456789/2115 | |
| dc.language.iso | en | en_US |
| dc.publisher | John Wiley and Sons Inc | en_US |
| dc.relation.ispartofseries | MedComm;Article number e163 | |
| dc.subject | administration routes | en_US |
| dc.subject | cancer | en_US |
| dc.subject | controlled drug delivery | en_US |
| dc.subject | nanomedicines | en_US |
| dc.title | Nanomedicine and versatile therapies for cancer treatment | en_US |
| dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- MedComm - 2022 - Shukla - Nanomedicine and versatile therapies for cancer treatment.pdf
- Size:
- 5.26 MB
- Format:
- Adobe Portable Document Format
- Description:
- Review - Gold Open Access
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: